cardiovascular outcomes people anticoagulation (compass) trial (Bayer AG)
90
Structured Review
Bayer AG
cardiovascular outcomes people anticoagulation (compass) trial
Cardiovascular Outcomes People Anticoagulation (Compass) Trial, supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cardiovascular+outcomes+people+anticoagulation+(compass)+trial/cardiovascular+outcomes+people+anticoagulation++compass++trial/pm36409491-187-10-17
Average 90 stars, based on 1 article reviews
Cardiovascular Outcomes People Anticoagulation (Compass) Trial, supplied by Bayer AG, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/cardiovascular+outcomes+people+anticoagulation+(compass)+trial/cardiovascular+outcomes+people+anticoagulation++compass++trial/pm36409491-187-10-17
Average 90 stars, based on 1 article reviews
cardiovascular outcomes people anticoagulation (compass) trial - by Bioz Stars,
2026-10
90/100 stars
Images
Related Articles
other:Article Title: Comparison of Investigator-Reported vs Centrally Adjudicated Major Adverse Cardiac Events: A Secondary Analysis of the COMPASS Trial. Article Snippet: Funding/Support: This work and the Cardiovascular Outcomes for People Using Article Title: Rivaroxaban 2.5 mg Twice Daily Plus Aspirin Reduces Venous Thromboembolism in Patients With Chronic Atherosclerosis Article Snippet: The |